Johnson JA - Search Results

1

Johnson JA, Connolly M, Zuberbuhler P, Brown NE. Johnson JA, et al. Pharmacotherapy. 2000 Oct;20(10):1167-74. doi: 10.1592/phco.20.15.1167.34583. Pharmacotherapy. 2000. PMID: 11034039

2

Health-related quality of life of diabetic Pima Indians.

Johnson JA, Nowatzki TE, Coons SJ. Johnson JA, et al. Med Care. 1996 Feb;34(2):97-102. doi: 10.1097/00005650-199602000-00001. Med Care. 1996. PMID: 8632692

3

Replicability of SF-36 summary scores by the SF-12 in stroke patients.

Pickard AS, Johnson JA, Penn A, Lau F, Noseworthy T. Pickard AS, et al. Among authors: johnson ja. Stroke. 1999 Jun;30(6):1213-7. doi: 10.1161/01.str.30.6.1213. Stroke. 1999. PMID: 10356102

4

Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk.

Tsuyuki RT, Johnson JA, Teo KK, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Simpson SH, Taylor JG. Tsuyuki RT, et al. Among authors: johnson ja. Ann Pharmacother. 1999 Sep;33(9):910-9. doi: 10.1345/aph.18380. Ann Pharmacother. 1999. PMID: 10492489 Clinical Trial.

5

Cost of care for individuals with cystic fibrosis: a regression approach to determining the impact of recombinant human DNase.

Johnson JA, Connolly MA, Jacobs P, Montgomery M, Brown NE, Zuberbuhler P. Johnson JA, et al. Pharmacotherapy. 1999 Oct;19(10):1159-66. doi: 10.1592/phco.19.15.1159.30580. Pharmacotherapy. 1999. PMID: 10512065

6

The impact of pharmacist interventions on health-related quality of life.

Pickard AS, Johnson JA, Farris KB. Pickard AS, et al. Among authors: johnson ja. Ann Pharmacother. 1999 Nov;33(11):1167-72. doi: 10.1345/aph.18460. Ann Pharmacother. 1999. PMID: 10573313

7

Measuring quality of life in paediatric patients.

Connolly MA, Johnson JA. Connolly MA, et al. Among authors: johnson ja. Pharmacoeconomics. 1999 Dec;16(6):605-25. doi: 10.2165/00019053-199916060-00002. Pharmacoeconomics. 1999. PMID: 10724790 Review.

8

Using focus groups to identify barriers to drug use in patients with congestive heart failure.

Simpson SH, Farris KB, Johnson JA, Tsuyuki RT. Simpson SH, et al. Among authors: johnson ja. Pharmacotherapy. 2000 Jul;20(7):823-9. doi: 10.1592/phco.20.9.823.35205. Pharmacotherapy. 2000. PMID: 10907972 Clinical Trial.

9

Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure.

Johnson JA, Ohinmaa A, Murti B, Sintonen H, Coons SJ. Johnson JA, et al. Med Decis Making. 2000 Jul-Sep;20(3):281-9. doi: 10.1177/0272989X0002000304. Med Decis Making. 2000. PMID: 10929850

10

Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists.

Simpson SH, Johnson JA, Tsuyuki RT. Simpson SH, et al. Among authors: johnson ja. Pharmacotherapy. 2001 May;21(5):627-35. doi: 10.1592/phco.21.6.627.34538. Pharmacotherapy. 2001. PMID: 11349751 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,772 results

Search Page

Filters